-
1دورية أكاديمية
المؤلفون: Blommestein, Hedwig M., de Groot, Saskia, Aarts, Mieke J., Vemer, Pepijn, de Vries, Robin, van Abeelen, Annet F. M., Posthuma, E. F. M. Ward, Uyl-de Groota, Carin A.
المصدر: Blommestein , H M , de Groot , S , Aarts , M J , Vemer , P , de Vries , R , van Abeelen , A F M , Posthuma , E F M W & Uyl-de Groota , C A 2016 , ' Cost-effectiveness of obinutuzumab for chronic lymphocytic leukaemia in The Netherlands ' , Leukemia Research , vol. 50 , pp. 37-45 . https://doi.org/10.1016/j.leukres.2016.09.005Test
مصطلحات موضوعية: Chronic lymphocytic leukaemia, Obinutuzumab, Chlorambucil, Rituximab, Ofatumumab, Cost-effectiveness, Costs, FLUDARABINE
وصف الملف: application/pdf
الإتاحة: https://doi.org/10.1016/j.leukres.2016.09.005Test
https://hdl.handle.net/11370/26e14c36-2e84-4b65-8893-b86603460341Test
https://research.rug.nl/en/publications/26e14c36-2e84-4b65-8893-b86603460341Test
https://pure.rug.nl/ws/files/40285564/Cost_effectiveness_of_obinutuzumab_for_chronic_lymphocytic_leukaemia_in_The_Netherlands.pdfTest -
2دورية أكاديمية
المؤلفون: Thielen, Frederick W, Kersten, Marie-José, Kuizenga, Pim, Hoogendoorn, Mels, Posthuma, Eduardus FM, Stevens, Wendy BC, A Uyl-de Groot, Carin, Blommestein, Hedwig M
المصدر: Expert Review of Anticancer Therapy; Dec 2021, Vol. 21 Issue 12, p1411-1422, 12p
مصطلحات موضوعية: FOLLICULAR lymphoma, LENALIDOMIDE, RITUXIMAB, COST effectiveness, QUALITY-adjusted life years
-
3دورية أكاديمية
المؤلفون: Blommestein, Hedwig M.1, Issa, Djamila E.2, Pompen, Marjolein3,4, Ten Hoor, Gerhard3, Hogendoorn, Mels5, Joosten, Peter5, Zweegman, Sonja2, Huijgens, Peter C.2, Uyl‐de Groot, Carin A.1
المصدر: European Journal of Haematology. May2014, Vol. 92 Issue 5, p398-406. 9p.
مصطلحات موضوعية: *COST effectiveness, *RITUXIMAB, *DRUG efficacy, *LYMPHOMA treatment, *MARKOV processes, *CANCER chemotherapy